Linked Life Data

11090062

Source:http://linkedlifedata.com/resource/pubmed/id/11090062

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11090062rdf:typepubmed:Citationlld:pubmed
pubmed-article:11090062lifeskim:mentionsumls-concept:C0018951lld:lifeskim
pubmed-article:11090062lifeskim:mentionsumls-concept:C0388911lld:lifeskim
pubmed-article:11090062lifeskim:mentionsumls-concept:C0169539lld:lifeskim
pubmed-article:11090062lifeskim:mentionsumls-concept:C0378796lld:lifeskim
pubmed-article:11090062lifeskim:mentionsumls-concept:C0086982lld:lifeskim
pubmed-article:11090062pubmed:issue12lld:pubmed
pubmed-article:11090062pubmed:dateCreated2000-12-11lld:pubmed
pubmed-article:11090062pubmed:abstractTextSignaling by vascular endothelial growth factors (VEGFs) through VEGF receptors (VEGFRs) plays important roles in vascular development and hematopoiesis. The authors analyzed the function of VEGF-C signaling through both VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis using a coculture of para-aortic splanchnopleural mesoderm (P-Sp) explants from mouse embryos with stromal cells (OP9). Vasculogenesis and angiogenesis were evaluated by the extent of vascular bed and network formation, respectively. Addition of VEGF-C to the P-Sp culture enhanced vascular bed formation and suppressed definitive hematopoiesis. Both vascular bed and network formations were completely suppressed by addition of soluble VEGFR-1-Fc competitor protein. Formation of vascular beds but not networks could be rescued by VEGF-C in the presence of the competitor, while both were rescued by VEGF-A. VEGFR-3-deficient embryos show the abnormal vasculature and severe anemia. Consistent with these in vivo findings, vascular bed formation in the P-Sp from the VEGFR-3-deficient embryos was enhanced to that in wild-type or heterozygous embryos, and hematopoiesis was severely suppressed. When VEGFR-3-Fc chimeric protein was added to trap endogenous VEGF-C in the P-Sp culture of the VEGFR-3-deficient embryos, vascular bed formation was suppressed and hematopoiesis was partially rescued. These results demonstrate that because VEGF-C signaling through VEGFR-2 works synergistically with VEGF-A, the binding of VEGF-C to VEGFR-3 consequently regulates VEGFR-2 signaling. In VEGFR-3-deficient embryos, an excess of VEGF-C signals through VEGFR-2 induced the disturbance of vasculogenesis and hematopoiesis during embryogenesis. This indicates that elaborated control through VEGFR-3 signaling is critical in vasculoangiogenesis and hematopoiesis. (Blood. 2000;96:3793-3800)lld:pubmed
pubmed-article:11090062pubmed:languageenglld:pubmed
pubmed-article:11090062pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11090062pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11090062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11090062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11090062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11090062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11090062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11090062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11090062pubmed:statusMEDLINElld:pubmed
pubmed-article:11090062pubmed:monthDeclld:pubmed
pubmed-article:11090062pubmed:issn0006-4971lld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:ItoYYlld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:SudaTTlld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:HamadaKKlld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:AlitaloKKlld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:OikeYYlld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:TakakuraNNlld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:DumontD JDJlld:pubmed
pubmed-article:11090062pubmed:authorpubmed-author:JussilaLLlld:pubmed
pubmed-article:11090062pubmed:issnTypePrintlld:pubmed
pubmed-article:11090062pubmed:day1lld:pubmed
pubmed-article:11090062pubmed:volume96lld:pubmed
pubmed-article:11090062pubmed:ownerNLMlld:pubmed
pubmed-article:11090062pubmed:authorsCompleteYlld:pubmed
pubmed-article:11090062pubmed:pagination3793-800lld:pubmed
pubmed-article:11090062pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:meshHeadingpubmed-meshheading:11090062...lld:pubmed
pubmed-article:11090062pubmed:year2000lld:pubmed
pubmed-article:11090062pubmed:articleTitleVEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.lld:pubmed
pubmed-article:11090062pubmed:affiliationDepartment of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kumamoto University, Japan.lld:pubmed
pubmed-article:11090062pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11090062pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:14254entrezgene:pubmedpubmed-article:11090062lld:entrezgene
entrez-gene:14257entrezgene:pubmedpubmed-article:11090062lld:entrezgene
entrez-gene:16542entrezgene:pubmedpubmed-article:11090062lld:entrezgene
entrez-gene:18613entrezgene:pubmedpubmed-article:11090062lld:entrezgene
entrez-gene:22339entrezgene:pubmedpubmed-article:11090062lld:entrezgene
entrez-gene:22341entrezgene:pubmedpubmed-article:11090062lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11090062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11090062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11090062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11090062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11090062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11090062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11090062lld:pubmed